Endocrinology, Vol 127, 3215-3221, Copyright © 1990 by Endocrine Society

ARTICLES

Sequential expression of phenotype markers for osteoclasts during differentiation of precursors for multinucleated cells formed in long- term human marrow cultures

N Kurihara, S Gluck and GD Roodman
Research Service, Veterans Administration Medical Center, San Antonio, Texas.

Long-term human marrow cultures form multi-nucleated cells (MNC) which express the osteoclast phenotype. Mononuclear precursors for these MNC can be identified and highly enriched. We tested early (bipotent) and late (unipotent) precursors of these MNC for expression of several osteoclast differentiation markers: 1) the osteoclast vitronectin receptor, identified by the 23c6 monoclonal antibody, 2) the vacuolar- type proton pump, identified by the E11 monoclonal antibody, and 3) the calcitonin (CT) receptor, by autoradiography with 125I-labeled salmon calcitonin. We wished to determine if the proton pump was expressed in cells in long term marrow cultures and if its expression correlated with expression of the CT receptor and the vitronectin receptor. About 30% of early precursor cells reacted with the 23c6 monoclonal antibody, but none expressed CT receptors or showed amplified proton pump expression. The CT receptor and amplified proton pump expression were detected first on the late precursor, a stage in which every cell reacted strongly with the 23c6 monoclonal antibody. Over 80% of MNC formed from these late precursors expressed abundant CT receptors, and all MNC expressed the vitronectin receptor and showed amplified proton pump expression. In contrast, macrophage polykaryons and mononuclear macrophages formed in vitro failed to express the osteoclast vitronectin and CT receptors and expressed the proton pump at levels indistinguishable from those of surrounding cells.

This article has been cited by other articles:

				M. S. Kim, C. J. Day, C. I. Selinger, C. L. Magno, S. R. J. Stephens, and N. A. Morrison MCP-1-induced Human Osteoclast-like Cells Are Tartrate-resistant Acid Phosphatase, NFATc1, and Calcitonin Receptor-positive but Require Receptor Activator of NF{kappa}B Ligand for Bone Resorption J. Biol. Chem., January 13, 2006; 281(2): 1274 - 1285. [Abstract] [Full Text] [PDF]

				A. Rivollier, M. Mazzorana, J. Tebib, M. Piperno, T. Aitsiselmi, C. Rabourdin-Combe, P. Jurdic, and C. Servet-Delprat Immature dendritic cell transdifferentiation into osteoclasts: a novel pathway sustained by the rheumatoid arthritis microenvironment Blood, December 15, 2004; 104(13): 4029 - 4037. [Abstract] [Full Text] [PDF]

				A. R. Pettit, H. Ji, D. von Stechow, R. Muller, S. R. Goldring, Y. Choi, C. Benoist, and E. M. Gravallese TRANCE/RANKL Knockout Mice Are Protected from Bone Erosion in a Serum Transfer Model of Arthritis Am. J. Pathol., November 1, 2001; 159(5): 1689 - 1699. [Abstract] [Full Text] [PDF]

				T Laitala-Leinonen, C Lowik, S Papapoulos, and H. Vaananen Inhibition of intravacuolar acidification by antisense RNA decreases osteoclast differentiation and bone resorption in vitro J. Cell Sci., January 11, 1999; 112(21): 3657 - 3666. [Abstract] [PDF]

				I. Nakamura, H. Tanaka, G. A. Rodan, and L. T. Duong Echistatin Inhibits the Migration of Murine Prefusion Osteoclasts and the Formation of Multinucleated Osteoclast-Like Cells Endocrinology, December 1, 1998; 139(12): 5182 - 5193. [Abstract] [Full Text] [PDF]

				H. Harada, T. Kukita, A. Kukita, Y. Iwamoto, and T. Iijima Involvement of Lymphocyte Function-Associated Antigen-1 and Intercellular Adhesion Molecule-1 in Osteoclastogenesis: A Possible Role in Direct Interaction between Osteoclast Precursors Endocrinology, September 1, 1998; 139(9): 3967 - 3975. [Abstract] [Full Text] [PDF]

				N. Kurihara, C. Menaa, H. Maeda, D. J. Haile, and S. V. Reddy Osteoclast-stimulating Factor Interacts with the Spinal Muscular Atrophy Gene Product to Stimulate Osteoclast Formation J. Biol. Chem., October 26, 2001; 276(44): 41035 - 41039. [Abstract] [Full Text] [PDF]